RPG Life Sciences Limited (RPGLIFE) - Total Assets

Latest as of March 2026: Rs7.93 Billion INR ≈ $85.78 Million USD

Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) holds total assets worth Rs7.93 Billion INR (≈ $85.78 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore RPG Life Sciences Limited cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

RPG Life Sciences Limited - Total Assets Trend (2005–2026)

This chart illustrates how RPG Life Sciences Limited's total assets have evolved over time, based on quarterly financial data. See shareholders equity of RPG Life Sciences Limited for net asset value and shareholders' equity analysis.

RPG Life Sciences Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

RPG Life Sciences Limited's total assets of Rs7.93 Billion consist of 70.5% current assets and 29.5% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	24.2%
Accounts Receivable	Rs1.17 Billion	14.7%
Inventory	Rs1.24 Billion	15.6%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs81.10 Million	1.0%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2005–2026)

This chart illustrates how RPG Life Sciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of RPG Life Sciences Limited.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: RPG Life Sciences Limited's current assets represent 70.5% of total assets in 2026, an increase from 29.2% in 2005.
Cash Position: Cash and equivalents constituted 24.2% of total assets in 2026, up from 0.3% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2005.
Asset Diversification: The largest asset category is inventory at 15.6% of total assets.

RPG Life Sciences Limited Competitors by Total Assets

Key competitors of RPG Life Sciences Limited based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million
Jw Pharmac KO:001060	Korea	₩605.27 Billion
Kamada TA:KMDA	Israel	ILA377.21 Million
Samjin Pharm KO:005500	Korea	₩449.14 Billion

RPG Life Sciences Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.48	3.88	2.21
Quick Ratio	2.71	3.11	1.47
Cash Ratio	0.00	1.17	0.00
Working Capital	Rs3.99 Billion	Rs3.45 Billion	Rs961.60 Million

RPG Life Sciences Limited - Advanced Valuation Insights

This section examines the relationship between RPG Life Sciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	5.71
Latest Market Cap to Assets Ratio	0.06
Asset Growth Rate (YoY)	20.6%
Total Assets	Rs7.93 Billion
Market Capitalization	$493.09 Million USD

Valuation Analysis

Below Book Valuation: The market values RPG Life Sciences Limited's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: RPG Life Sciences Limited's assets grew by 20.6% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for RPG Life Sciences Limited (2005–2026)

The table below shows the annual total assets of RPG Life Sciences Limited from 2005 to 2026.

Year	Total Assets	Change
2026-03-31	Rs7.93 Billion ≈ $85.78 Million	+20.58%
2025-03-31	Rs6.58 Billion ≈ $71.14 Million	+28.26%
2024-03-31	Rs5.13 Billion ≈ $55.46 Million	+22.30%
2023-03-31	Rs4.19 Billion ≈ $45.35 Million	+21.69%
2022-03-31	Rs3.45 Billion ≈ $37.27 Million	+13.59%
2021-03-31	Rs3.03 Billion ≈ $32.81 Million	+13.74%
2020-03-31	Rs2.67 Billion ≈ $28.85 Million	+6.17%
2019-03-31	Rs2.51 Billion ≈ $27.17 Million	-13.74%
2018-03-31	Rs2.91 Billion ≈ $31.50 Million	+18.27%
2017-03-31	Rs2.46 Billion ≈ $26.63 Million	+20.00%
2016-03-31	Rs2.05 Billion ≈ $22.19 Million	+4.23%
2015-03-31	Rs1.97 Billion ≈ $21.30 Million	+0.43%
2014-03-31	Rs1.96 Billion ≈ $21.20 Million	-4.71%
2013-03-31	Rs2.06 Billion ≈ $22.25 Million	+12.50%
2012-03-31	Rs1.83 Billion ≈ $19.78 Million	-4.19%
2011-03-31	Rs1.91 Billion ≈ $20.64 Million	+14.06%
2010-03-31	Rs1.67 Billion ≈ $18.10 Million	-0.33%
2009-03-31	Rs1.68 Billion ≈ $18.16 Million	-4.27%
2008-03-31	Rs1.75 Billion ≈ $18.97 Million	-14.63%
2007-03-31	Rs2.05 Billion ≈ $22.22 Million	-6.36%
2006-03-31	Rs2.19 Billion ≈ $23.73 Million	-6.71%
2005-03-31	Rs2.35 Billion ≈ $25.44 Million	--

About RPG Life Sciences Limited

NSE:RPGLIFE India Drug Manufacturers - Specialty & Generic

Market Cap

$493.09 Million

Rs45.59 Billion INR

Market Cap Rank

#12149 Global

#615 in India

Share Price

Rs2756.80

Change (1 day)

-0.41%

52-Week Range

Rs1744.00 - Rs3017.10

All Time High

Rs3017.10